Form 4: Nuvalent Director Matthew Shair Executes Stock Sales Under 10b5-1 Plan

Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on March 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 25, 2024, Matthew Shair, a director of Nuvalent, Inc. (NUVL), executed multiple sales of Class A Common Stock.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 37,495 shares were sold in direct transactions at weighted average prices ranging from $76.74 to $77.37.
• Additionally, 2,000 shares held indirectly through the Matthew D. Shair 2021 Irrevocable Family Trust were sold at weighted average prices ranging from $76.74 to $77.37.
• Following these transactions, Shair directly owns 1,687,198 shares and indirectly owns 238,522 shares through the family trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company directors are a normal part of business, but are closely watched by investors.

Stakeholder Impact

• The stock sales by a director could be perceived negatively by some shareholders, potentially leading to slight downward pressure on the stock price.

Key Dates